165 studies found for:    Open Studies | "Lung Diseases, Interstitial"
Show Display Options
Rank Status Study
21 Unknown  Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
Conditions: Pulmonary Hypertension;   Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis;   Nonspecific Interstitial Pneumonia
Interventions: Drug: Bosentan;   Drug: Placebo
22 Unknown  Pulmonary Hypertension in Interstitial Lung Disease
Conditions: Pulmonary Arterial Hypertension;   Diffuse Interstitial Lung Disease
Intervention:
23 Unknown  Evaluating N-Acetylcysteine in CTD-ILD Treatment
Conditions: Interstitial Lung Disease;   Connective Tissue Disease
Intervention: Drug: N-Acetylcysteine
24 Recruiting Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
Conditions: Interstitial Lung Disease;   Scleroderma;   Idiopathic Inflammatory Myositis;   Mixed Connective Tissue Disease
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide
25 Recruiting Identification of Novel Markers of Human Lung Disease
Condition: Lung Diseases, Interstitial
Intervention: Other: novel biomarkers of lung disease
26 Recruiting Rituximab in Interstitial Pneumonitis
Conditions: Lung Diseases, Interstitial;   Pneumonitis, Interstitial
Interventions: Drug: Rituximab;   Radiation: Zr-89-rituximab immuno PET/CT
27 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
28 Recruiting Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease
Conditions: Chronic Obstructive Lung Disease (n=10);   Interstitial Lung Disease (n=10)
Intervention: Other: Whole body vibration
29 Recruiting Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Diffuse Parenchymal Lung Disease;   Interstitial Lung Disease
Interventions: Drug: sirolimus;   Other: Placebo
30 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
31 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
32 Recruiting Prediction of Everolimus-induced Interstitial Lung Disease
Condition: Breast Neoplasms
Intervention:
33 Not yet recruiting Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   ILD;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Bortezomib;   Drug: Placebo;   Drug: Mycophenolate mofetil
34 Not yet recruiting Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Conditions: Scleroderma;   Interstitial Lung Disease
Intervention: Drug: dabigatran etexilate
35 Recruiting Comparison Study of the Effectiveness of Endobronchial Ultrasound Transbronchial Aspiration (EBUS-TBNA) Preformed With and Without an Inner Stylet in the Biopsy Needle
Condition: Interstitial Lung Disease
Intervention: Other: EBUS without stylet
36 Recruiting Blood Collection From Individuals With Lung Disease for Genetic Studies
Conditions: Asthma;   COPD;   Interstitial Lung Disease;   Cystic Fibrosis;   Lung Cancer
Intervention:
37 Recruiting Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Conditions: Asthma;   Chronic Obstructive Pulmonary Disease;   Interstitial Lung Disease;   Cystic Fibrosis;   Pulmonary Hypertension
Intervention: Drug: Xenon
38 Recruiting The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis
Conditions: Interstitial Lung Disease;   Systemic Sclerosis;   Gastroesophageal Reflux
Intervention: Other: Gastro-esophageal reflux
39 Unknown  Endoplasmic Reticulum Stress in Chronic Respiratory Diseases
Conditions: ER Stress,;   Chronic Airway Disorders,;   Lung Cancer,;   Interstitial Lung Diseases
Intervention:
40 Recruiting GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Conditions: Lupus Erythematosus, Systemic;   Systemic Vasculitis;   Isolated Angiitis of Central Nervous System;   Lung Disease With Systemic Sclerosis;   Lung Disease Interstitial Diffuse
Interventions: Drug: depot leuprolide acetate 3.75 mg;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years